- Home
- ADXN vs FRTT Comparison
ADXN vs FRTT Comparison
Compare ADXN & FRTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADXN | FRTT |
|---|---|---|
| Founded | 2002 | N/A |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6M | 10.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADXN | FRTT |
|---|---|---|
| Price | $5.89 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.4K | ★ 876.4K |
| Earning Date | 04-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $86.57 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.41 | $0.72 |
| 52 Week High | $12.05 | $3.92 |
Technical Indicators
Market Signals| Indicator | ADXN | FRTT |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 33.21 |
| Support Level | $5.53 | $0.75 |
| Resistance Level | $7.37 | $0.97 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 33.53 | 30.53 |
Price Performance
Historical ComparisonAbout ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About FRTT Fort Technology Inc. Common Shares
Fort Technology Inc is engaged the identification and evaluation of assets or business with a view to potentially acquire them or an interest therein by an option or any concomitant transaction.